Stage 4 pancreatic cancer treatment options have evolved significantly beyond chemotherapy alone, with personalized approaches now guiding decisions based on tumor biology, genetic markers, performance status, and patient goals rather than one-size-fits-all protocols. TL;DR Only 15 to 20% of pancreatic cancers are diagnosed at a potentially resectable stage, making stage 4 treatment focused on extending life, managing symptoms, and maintaining quality of life [1] FOLFIRINOX a

TL;DR: What to Do When Chemotherapy Doesn't Work for Mouth Cancer When first-line chemotherapy fails, immunotherapy drugs like pembrolizumab have shown response rates in patients with oral cancer, particularly those with PD-L1 positive tumors [1] Dr. Bharat Patodiya precision oncology approach includes comprehensive biomarker testing to identify treatment resistance mechanisms and guide second-line therapy selection Targeted therapies, clinical trials, and combination treatme